In April 2025, Alector and GSK completed enrollment ahead of schedule in PROGRESS-AD, a global, randomized, double-blind, ...

Vesper Bio achieves enrolment milestone in Phase Ib/IIa trial of lead candidate VES001 for frontotemporal dementia Phase Ib/IIa trial is to evaluate the efficacy of VES001 in asymptomatic patients ...

The publication in Nature can be accessed via this link.

One previous study showed that a cohort of 68 patients with FTD worsened by an average of 3.57 points over a 12-month period per the Clinical Dementia Rating - Frontotemporal Lobar Degeneration ...

In addition, it is developing therapies for frontotemporal lobar degeneration, Huntington’s disease, progressive supranuclear palsy, corticobasal degeneration, and schizophrenia. The company was ...

Introduction Frontotemporal Lobar Degeneration (FTLD) commonly presents with a collapse in emotional and social awareness coupled with a failure to appreciate the consequences of the patient's own ...

and frontotemporal lobar degeneration (FTLD) respectively. Results Of 150 patients administered the MoCA (Int Psychogeriatr 2012;24:391–6), subscores were calculated for those with target diagnoses.

Oklahoma House designates last week of September as FTD Awareness Week, highlighting the challenges of frontotemporal ...

Frontotemporal dementia has gained significant attention in recent years after the family of actor Bruce Willis announced in 2023 that he had been diagnosed with the condition. A year later ...